Validation of Liver Imaging Reporting and Data System 2017 (LI‐RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma
- 26 September 2018
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 49 (7) , E205-E215
Abstract
Background: The Liver Imaging Reporting and Data System (LI‐RADS) is being adapted by many clinical practices. To support continuation of its use, LI‐RADS (LR) is in need of multicenter validation studies of recent LI‐RADS iterations. Furthermore, while both gadoxetate and extracellular agents have been incorporated into LI‐RADS, comparison of the diagnostic performance between the two has yet to be determined.Purpose/Hypothesis: To evaluate the rate, diagnostic performance, and interreader reliability (IRR) of LI‐RADS 2017 for hepatocellular carcinoma, including LR major and ancillary features, with both gadoxetate and extracellular agent‐enhanced MRI against a reference standard of histopathology or imaging follow‐up.Study Type: Retrospective.Population: In all, 114 patients with 144 observations were included who met LR 2017 criteria for at risk and had at least one hepatic observation on liver MRI performed with either gadoxetate (n = 52) or an extracellular agent (n = 92) between 2010–2016, with histopathology (n = 103) or follow‐up imaging (n = 41).Field Strength/Sequence: 1.5 and 3.0T/T1‐T2WI, diffusion‐weighted imaging.Assessment: Three radiologists independently assessed major/ancillary features and assigned overall LI‐RADS category for every observation.Statistical Tests: Diagnostic performance of LR5/TIV+LR5 for identifying hepatocellular carcinoma (HCC) was compared between contrast agents with a generalized estimating equation. Weighted kappa was performed for interrater reliability.Results: The frequency of HCCs among LR1, LR2, LR3, L4, LR5, LRTIV+LR5, and LRM observations were: 0% (all readers), 0–12.5%, 11.4–26.9%, 50–76%, 83.0–95.1%, 83.3–100.0%, and 45.0–65.0%, respectively. Sensitivity of LR5/LRTIV+LR5 for HCC was 59.7–71.4% and specificity 85.0–96.8%. LI‐RADS specificity and positive predictive value for observations imaged with gadoxetate was higher than extracellular agent for the most inexperienced reader (R3) (P = 0.009–0.034). IRR for LI‐RADS categorization was substantial (k = 0.661).Data Conclusion: Increasing numerical LI‐RADS 2017 categories demonstrate a greater percentage of HCCs. LR5/TIV+LR5 demonstrates excellent specificity and fair sensitivity for HCC. MRI with gadoxetate in liver transplant candidates may be beneficial for less experienced readers, although further large‐scale prospective studies are needed.Level of Evidence: 4Technical Efficacy: Stage 3J. Magn. Reson. Imaging 2019;49:e205–e215.Keywords
This publication has 19 references indexed in Scilit:
- LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directionsHepatology, 2014
- Comparison of Acute Transient Dyspnea after Intravenous Administration of Gadoxetate Disodium and Gadobenate Dimeglumine: Effect on Arterial Phase Image QualityRadiology, 2013
- New OPTN/UNOS Policy for Liver Transplant Allocation: Standardization of Liver Imaging, Diagnosis, Classification, and Reporting of Hepatocellular CarcinomaRadiology, 2013
- Hepatocellular MR contrast agents: Enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumineEuropean Journal of Radiology, 2012
- Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liverEuropean Journal of Radiology, 2011
- Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniquesHepatology, 2010
- Gadoxetate Disodium–Enhanced MRI of the Liver: Part 1, Protocol Optimization and Lesion Appearance in the Noncirrhotic LiverAmerican Journal of Roentgenology, 2010
- Gadoxetate Disodium–Enhanced MRI of the Liver: Part 2, Protocol Optimization and Lesion Appearance in the Cirrhotic LiverAmerican Journal of Roentgenology, 2010
- Liver vessel enhancement by gd-bopta and gd-eob-dtpa: a comparison in healthy volunteersActa Radiologica, 2009
- Dynamic contrast‐enhanced magnetic resonance imaging of abdominal solid organ and major vessel: Comparison of enhancement effect between Gd‐EOB‐DTPA and Gd‐DTPAJournal of Magnetic Resonance Imaging, 2009